DDi has been selected by a UK-based US $2B medical-device company to streamline its global regulatory strategy, intelligence operations, and regulatory assessments. The partnership strengthens compliance, accelerates market readiness, and leverages DDi’s advanced Visu regulatory-process platform.
DDi enhances its Visu platform with AI-driven project management tools, offering increased efficiency, real-time insights, and risk mitigation for pharma, biotech, and medical device industries.
DDi has been awarded the “Best Global Regulatory & Clinical Development Partner 2025” title by Global Health & Pharma. The award recognizes the company’s excellence in delivering regulatory and clinical solutions that streamline drug development and ensure global compliance.
DDi has launched an updated version of its ViSU eIFU platform, designed for medical device manufacturers to transition from traditional paper instructions to electronic formats. The platform supports regulatory compliance with global standards, including the EU MDR and FDA, while providing multi-language accessibility and an enhanced user experience.
DDi, a leader in life sciences technology and regulatory solutions, today announced new version with GenAI enabled smartDOC, an innovative automated content management platform designed to simplify content management.
Satisfied Users & 
Approved Press Releases
